February 2017
J2182 replaces J3490, J3590 when billing for Nucala® (mepolizumab)
The Centers for Medicare & Medicaid Services has established a permanent procedure code for Nucala® (mepolizumab), effective Jan. 1, 2017.
All services from Dec. 1, 2015, through Dec. 31, 2016, will continue to be reported with codes J3490 and J3590. All services performed on and after Jan. 1, 2017, must be reported with J2182.
Specialty pharmacy prior authorization is required for all groups unless they have opted out of the Prior Authorization program.
|